Maintenance therapy for AML: are we there yet?
Blood
.
2019 Mar 28;133(13):1390-1392.
doi: 10.1182/blood-2019-02-897579.
Author
Andrew H Wei
1
Affiliation
1
The Alfred Hospital; Monash University.
PMID:
30923105
DOI:
10.1182/blood-2019-02-897579
No abstract available
Publication types
Comment
MeSH terms
Aged
Azacitidine*
Humans
Leukemia, Myeloid, Acute*
Maintenance Chemotherapy
Substances
Azacitidine